These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1846168)

  • 1. The partnership of academia and industry in pharmacologic research.
    Scolnick EM
    J Lab Clin Med; 1991 Jan; 117(1):8-14. PubMed ID: 1846168
    [No Abstract]   [Full Text] [Related]  

  • 2. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finasteride: a 5 alpha-reductase inhibitor.
    Steiner JF
    Clin Pharm; 1993 Jan; 12(1):15-23. PubMed ID: 7679063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finasteride: the first 5 alpha-reductase inhibitor.
    Sudduth SL; Koronkowski MJ
    Pharmacotherapy; 1993; 13(4):309-25; discussion 325-9. PubMed ID: 7689728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New options for patients with benign prostatic hyperplasia.
    Ellenberger B
    CMAJ; 1993 Feb; 148(4):543-7. PubMed ID: 7679313
    [No Abstract]   [Full Text] [Related]  

  • 7. Poor reports dog industry-academia liaison.
    Ready T
    Nat Med; 2002 Dec; 8(12):1338-9. PubMed ID: 15085880
    [No Abstract]   [Full Text] [Related]  

  • 8. Finasteride for benign prostatic hyperplasia.
    DuBeau CE
    N Engl J Med; 1993 Feb; 328(6):443. PubMed ID: 7678439
    [No Abstract]   [Full Text] [Related]  

  • 9. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry and academia in collaboration: the Pfizer experience.
    Price FD
    Circulation; 1985 Aug; 72(2 Pt 2):I13-7. PubMed ID: 4006152
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.
    Lopez D; Chambers CM; Ness GC
    Arch Biochem Biophys; 1997 Jul; 343(1):118-22. PubMed ID: 9210653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ
    Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gift from nature: the birth of the statins.
    Endo A
    Nat Med; 2008 Oct; 14(10):1050-2. PubMed ID: 18841147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on enzymes involved in cholesterol metabolism using inhibitors].
    Tomoda H
    Tanpakushitsu Kakusan Koso; 1994 Jul; 39(9):1532-47. PubMed ID: 7915848
    [No Abstract]   [Full Text] [Related]  

  • 16. The regulation of beta-secretase by cholesterol and statins in Alzheimer's disease.
    Sidera C; Parsons R; Austen B
    J Neurol Sci; 2005 Mar; 229-230():269-73. PubMed ID: 15760650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells.
    Zhou Q; Zhou Y; Kummerow FA
    Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):1-7. PubMed ID: 19135546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening up the Ivory Tower.
    Wilan KH
    Cell; 2007 Jun; 129(5):847-50. PubMed ID: 17540161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of finasteride on the rat ventral prostate.
    Shao TC; Kong A; Marafelia P; Cunningham GR
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.